ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel.

Jinhua Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.